Cardiovascular effects of 1 year of alagebrium and endurance exercise training in healthy older individuals

Circulation: Heart Failure

Volumn 6, Issue 6, 2013, Pages 1155-1164

  Fujimoto, Naoki ^a,b   Hastings, Jeffrey L ^a,b   Carrick Ranson, Graeme ^a,b   Shafer, Keri M ^a,b   Shibata, Shigeki ^a,b   Bhella, Paul S ^a,b   Abdullah, Shuaib M ^a   Barkley, Kyler W ^a   Adams Huet, Beverley ^a   Boyd, Kara N ^a,b   Livingston, Sheryl A ^b   Palmer, Dean ^b   Levine, Benjamin D ^b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b PRESBYTERIAN HOSPITAL OF DALLAS   (United States)

Author keywords

Aging; Alagebrium; Cardiac function tests; Hemodynamics

Indexed keywords

ALAGEBRIUM; PLACEBO; THIAZOLE DERIVATIVE;

ADULT; AGED; ARTERY COMPLIANCE; ARTICLE; CARDIOPULMONARY EXERCISE TEST; CARDIOVASCULAR EFFECT; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; ENDURANCE TRAINING; EXERCISE; FEMALE; GASTROINTESTINAL SYMPTOM; HEART CATHETERIZATION; HEART LEFT VENTRICLE COMPLIANCE; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE PRESSURE; HEART LEFT VENTRICLE VOLUME; HEART SIZE; HEART VENTRICLE FILLING; HUMAN; MALE; MIDDLE AGED; NORMAL HUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; PULMONARY ARTERY OCCLUSION PRESSURE; RANDOMIZED CONTROLLED TRIAL; REPEAT PROCEDURE; SEDENTARY LIFESTYLE; UNSPECIFIED SIDE EFFECT; VERY ELDERLY; AGING; CARDIOVASCULAR SYSTEM; COMPARATIVE STUDY; DOSE RESPONSE; DRUG EFFECTS; EXERCISE TEST; EXERCISE TOLERANCE; FOLLOW UP; HEART LEFT VENTRICLE FUNCTION; HEART VENTRICLE; PHYSIOLOGY; REFERENCE VALUE; TIME; CARDIAC FUNCTION TESTS; CONTROLLED CLINICAL TRIAL; HEMODYNAMICS;

AGED; AGED, 80 AND OVER; AGING; CARDIOVASCULAR SYSTEM; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; FOLLOW-UP STUDIES; HEART VENTRICLES; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REFERENCE VALUES; THIAZOLES; TIME FACTORS; VENTRICULAR FUNCTION, LEFT;

AGING; ALAGEBRIUM; CARDIAC FUNCTION TESTS; HEMODYNAMICS;

EID: 84892634754     PISSN: 19413289     EISSN: 19413297     Source Type: Journal    
DOI: 10.1161/CIRCHEARTFAILURE.113.000440     Document Type: Article

References (35)

1. Lakatta EG, Levy D. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part I: aging arteries: a "set up" for vascular disease. Circulation. 2003;107:139-146.
2. Fujimoto N, Hastings JL, Bhella PS, Shibata S, Gandhi NK, Carrick- Ranson G, Palmer D, Levine BD. Effect of ageing on left ventricular compliance and distensibility in healthy sedentary humans. J Physiol. 2012;590(pt 8):1871-1880.
3. Prasad A, Hastings JL, Shibata S, Popovic ZB, Arbab-Zadeh A, Bhella PS, Okazaki K, Fu Q, Berk M, Palmer D, Greenberg NL, Garcia MJ, Thomas JD, Levine BD. Characterization of static and dynamic left ventricular diastolic function in patients with heart failure with a preserved ejection fraction. Circ Heart Fail. 2010;3:617-626.
4. Arbab-Zadeh A, Dijk E, Prasad A, Fu Q, Torres P, Zhang R, Thomas JD, Palmer D, Levine BD. Effect of aging and physical activity on left ventricular compliance. Circulation. 2004;110:1799-1805.
5. Fujimoto N, Prasad A, Hastings JL, Arbab-Zadeh A, Bhella PS, Shibata S, Palmer D, Levine BD. Cardiovascular effects of 1 year of progressive and vigorous exercise training in previously sedentary individuals older than 65 years of age. Circulation. 2010;122:1797-1805.
6. Brownlee M, Cerami A, Vlassara H. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med. 1988;318:1315-1321
7. Aronson D. Cross-linking of glycated collagen in the pathogenesis of arterial and myocardial stiffening of aging and diabetes. J Hypertens. 2003;21:3-12.
8. Zieman SJ, Kass DA. Advanced glycation endproduct crosslinking in the cardiovascular system: potential therapeutic target for cardiovascular disease. Drugs. 2004;64:459-470.
9. Asif M, Egan J, Vasan S, Jyothirmayi GN, Masurekar MR, Lopez S, Williams C, Torres RL, Wagle D, Ulrich P, Cerami A, Brines M, Regan TJ. An advanced glycation endproduct cross-link breaker can reverse age-related increases in myocardial stiffness. Proc Natl Acad Sci U S A. 2000;97:2809-2813.
10. Yan SF, Ramasamy R, Naka Y, Schmidt AM. Glycation, inflammation, and RAGE: a scaffold for the macrovascular complications of diabetes and beyond. Circ Res. 2003;93:1159-1169.
11. Yan SD, Schmidt AM, Anderson GM, Zhang J, Brett J, Zou YS, Pinsky D, Stern D. Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins. J Biol Chem. 1994;269:9889-9897.
12. Candido R, Forbes JM, Thomas MC, Thallas V, Dean RG, Burns WC, Tikellis C, Ritchie RH, Twigg SM, Cooper ME, Burrell LM. A breaker of advanced glycation end products attenuates diabetes-induced myocardial structural changes. Circ Res. 2003;92:785-792.
13. Vaitkevicius PV, Lane M, Spurgeon H, Ingram DK, Roth GS, Egan JJ, Vasan S, Wagle DR, Ulrich P, Brines M, Wuerth JP, Cerami A, Lakatta EG. A cross-link breaker has sustained effects on arterial and ventricular properties in older rhesus monkeys. Proc Natl Acad Sci U S A. 2001;98:1171-1175.
14. Little WC, Zile MR, Kitzman DW, Hundley WG, O?Brien TX, Degroof RC. The effect of alagebrium chloride (ALT-711), a novel glucose crosslink breaker, in the treatment of elderly patients with diastolic heart failure. J Card Fail. 2005;11:191-195.
15. Hartog JW, Willemsen S, van Veldhuisen DJ, Posma JL, van Wijk LM, Hummel YM, Hillege HL, Voors AA; BENEFICIAL Investigators. Effects of alagebrium, an advanced glycation endproduct breaker, on exercise tolerance and cardiac function in patients with chronic heart failure. Eur J Heart Fail. 2011;13:899-908.
16. Victor RG, Haley RW, Willett DL, Peshock RM, Vaeth PC, Leonard D, Basit M, Cooper RS, Iannacchione VG, Visscher WA, Staab JM, Hobbs HH; Dallas Heart Study Investigators. The Dallas Heart Study: a population- based probability sample for the multidisciplinary study of ethnic differences in cardiovascular health. Am J Cardiol. 2004;93:1473-1480.
17. Chen J, Das S, Barlow CE, Grundy S, Lakoski SG. Fitness, fatness, and systolic blood pressure: data from the Cooper Center Longitudinal Study. Am Heart J. 2010;160:166-170.
18. Blumenthal JA, Emery CF, Madden DJ, Coleman RE, Riddle MW, Schniebolk S, Cobb FR, Sullivan MJ, Higginbotham MB. Effects of exercise training on cardiorespiratory function in men and women older than 60 years of age. Am J Cardiol. 1991;67:633-639.
19. Hundley WG, Li HF, Willard JE, Landau C, Lange RA, Meshack BM, Hillis LD, Peshock RM. Magnetic resonance imaging assessment of the severity of mitral regurgitation. Comparison with invasive techniques. Circulation. 1995;92:1151-1158.
20. Katz J, Milliken MC, Stray-Gundersen J, Buja LM, Parkey RW, Mitchell JH, Peshock RM. Estimation of human myocardial mass with MR imaging. Radiology. 1988;169:495-498.
21. Hastings JL, Krainski F, Snell PG, Pacini EL, Jain M, Bhella PS, Shibata S, Fu Q, Palmer MD, Levine BD. Effect of rowing ergometry and oral volume loading on cardiovascular structure and function during bed rest. J Appl Physiol (1985). 2012;112:1735-1743.
22. Levine BD, Lane LD, Buckey JC, Friedman DB, Blomqvist CG. Left ventricular pressure-volume and Frank-Starling relations in endurance athletes. Implications for orthostatic tolerance and exercise performance. Circulation. 1991;84:1016-1023.
23. Laszlo G. Respiratory measurements of cardiac output: from elegant idea to useful test. J Appl Physiol (1985). 2004;96:428-437.
24. Chemla D, Hebert JL, Coirault C, Zamani K, Suard I, Colin P, Lecarpentier Y. Total arterial compliance estimated by stroke volume-to-aortic pulse pressure ratio in humans. Am J Physiol. 1998;274(2 pt 2):H500-H505.
25. Chen CH, Nakayama M, Nevo E, Fetics BJ, Maughan WL, Kass DA. Coupled systolic-ventricular and vascular stiffening with age: implications for pressure regulation and cardiac reserve in the elderly. J Am Coll Cardiol. 1998;32:1221-1227.
26. Kelly RP, Ting CT, Yang TM, Liu CP, Maughan WL, Chang MS, Kass DA. Effective arterial elastance as index of arterial vascular load in humans. Circulation. 1992;86:513-521.
27. Mirsky I. Assessment of diastolic function: suggested methods and future considerations. Circulation. 1984;69:836-841.
28. Dauterman K, Pak PH, Maughan WL, Nussbacher A, Ariê S, Liu CP, Kass DA. Contribution of external forces to left ventricular diastolic pressure. Implications for the clinical use of the Starling law. Ann Intern Med. 1995;122:737-742.
29. Belenkie I, Kieser TM, Sas R, Smith ER, Tyberg JV. Evidence for left ventricular constraint during open heart surgery. Can J Cardiol. 2002;18:951-959.
30. Glower DD, Spratt JA, Snow ND, Kabas JS, Davis JW, Olsen CO, Tyson GS, Sabiston DC Jr, Rankin JS. Linearity of the Frank-Starling relationship in the intact heart: the concept of preload recruitable stroke work. Circulation. 1985;71:994-1009.
31. Steppan J, Tran H, Benjo AM, Pellakuru L, Barodka V, Ryoo S, Nyhan SM, Lussman C, Gupta G, White AR, Daher JP, Shoukas AA, Levine BD, Berkowitz DE. Alagebrium in combination with exercise ameliorates age-associated ventricular and vascular stiffness. Exp Gerontol. 2012;47:565-572.
32. Kass DA, Shapiro EP, Kawaguchi M, Capriotti AR, Scuteri A, deGroof RC, Lakatta EG. Improved arterial compliance by a novel advanced glycation end-product crosslink breaker. Circulation. 2001;104:1464-1470.
33. Zieman SJ, Melenovsky V, Clattenburg L, Corretti MC, Capriotti A, Gerstenblith G, Kass DA. Advanced glycation endproduct crosslink breaker (alagebrium) improves endothelial function in patients with isolated systolic hypertension. J Hypertens. 2007;25:577-583.
34. Bakris GL, Bank AJ, Kass DA, Neutel JM, Preston RA, Oparil S. Advanced glycation end-product cross-link breakers. A novel approach to cardiovascular pathologies related to the aging process. Am J Hypertens. 2004;17(12 pt 2):23S-30S.
35. Wisløff U, Støylen A, Loennechen JP, Bruvold M, Rognmo ∅, Haram PM, Tjønna AE, Helgerud J, Slørdahl SA, Lee SJ, Videm V, Bye A, Smith GL, Najjar SM, Ellingsen ∅, Skjaerpe T. Superior cardiovascular effect of aerobic interval training versus moderate continuous training in heart failure patients: a randomized study. Circulation. 2007;115:3086-3094.